Clinical trial

TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk

NCT00179777 · University of Helsinki, Other · Completed

Key facts

NCT number NCT00179777
Title TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk
Official title TRIGR - Trial to Reduce IDDM in the Genetically at Risk
Acronym TRIGR
Lead sponsor University of Helsinki, Other
Collaborators United States Congress U.S. Fed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH Canadian Institutes of Health Research (CIHR) Juvenile Diabetes Research…
Status Completed
Study type Interventional
Conditions Diabetes Mellitus, Type 1
Intervention type Dietary Supplement
Interventions Hydrolysed infant formula, Nonhydrolysed infant formula
Enrollment 5,156
Start date May 6, 2002
Primary completion Mar 31, 2017
Completion Sep 30, 2017
First posted Sep 16, 2005
Last update posted Jul 30, 2021
Countries Australia, Canada, Czechia, Estonia, Finland, Germany, Hungary, Italy, Luxembourg, Netherlands, Poland, Spain and 3 more

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies